Endonovo Therapeutics, Inc. (ENDV): Gross Profit
Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$125.4K
Year ended 2022-12-31
-16.7%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $125.4K | +115.7% | 2023-04-17, From 2022-01-01 |
| 2021-12-31 | $58.1K | -42.1% | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $100.4K | -53.7% | 2022-04-14, From 2020-01-01 |
| 2019-12-31 | $216.8K | +208.2% | 2021-04-13, From 2019-01-01 |
| 2018-12-31 | $70.3K | n/a | 2020-05-04, From 2018-01-01 |
| No annual figure between 2015-12-31 and 2018-12-31. | |||
| 2015-12-31 | $2.1K | -75.8% | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | $8.7K | -2.2% | 2016-05-17, From 2014-01-01 |
| 2013-12-31 | $8.9K | n/a | 2015-06-15, From 2013-01-01 |